By the time patients start getting treated for brain cancer, their prognosis is often very poor, with an average survival of 14 months. Find out how early detection of cancers is emerging as a promising field of exploration.
Imagine using electricity to non-invasively treat and cure brain cancer. Or stroke. Or Parkinson’s. Or an aneurysm. Or Alzheimer’s, depression, concussion. Dr. Santosh Kesari is a physician scientist who sees the possibilities in the world of alternating electric field therapy.
Cancers are never confined by borders. For most disease types, the ones seen in clinics and institutions throughout the United States are the same found in other first-, second-, and third-world countries. The realities facing cancer, treatments, and patient outcomes are often challenging to address no matter where you live, and it’s one of the many common threads that tie oncology professionals together the world over. Read about the unique challenges faced in The Philippines.
Thanks to the ever-increasing availability of medical information available online and capabilities for long distance tele-health consultations, patients have many options to undergo multidisciplinary treatment for their conditions with experts worldwide. Find out if it is safe for patients with brain tumors to fly.
The Wizard201G clinical trial from Boston Biomedical Inc. is a vaccine treatment for patients with recurrent or progressive GBM following initial treatment. Pacific Neuroscience Institute is a site for this phase 2 study which is currently recruiting. Contact us for eligibility criteria at 310-582-7460.
Check out Pacific Neuroscience Institute’s advanced clinical trials line up for May 2018. PNI is very excited to announce a new clinical trial for the assessment and treatment of patients with newly diagnosed glioblastoma. Find out how Dr. Santosh Kesari’s protocol tackles brain cancer treatment in a whole new way.
Dr. Santosh Kesari’s new clinical trial approaches glioblastoma treatment in a whole new way. By giving immunotherapy first rather than radiation and chemotherapy, the patient’s immune system remains uncompromised which could result in better responses and lead to better patient outcomes.
Pacific Neuroscience Institute’s neurosurgery educational partnership exchange with Fudan University in Shanghai, China moves to the next level with a new live stream videoconference. Learn how this program is bringing minimally invasive endoscopic surgery knowledge across the globe.
Pacific Neuroscience Institute is pleased to announce a new clinical trial for traumatic brain injury patients who have been suffering from chronic motor deficits for more than a year. This study is currently enrolling patients. Clinical trials help bring much needed treatments and therapies to market. Find out more about PNI trials for treatment of primary brain tumors such as glioblastoma, metastatic brain tumors that arise from cancers affecting the breast, lung or skin, quality and outcomes research and other neurological studies.
Dr. Walavan Sivakumar, director of neurosurgery at Providence Little Company of Mary Medical talks about the one of a kind Pacific Neuroscience Institute clinic. The center offers comprehensive services for treating a wide spectrum of neurological and cranial disorders. Check out this great and informative interview with NEWSBREAK Live.